NANOTOMER
NanoTomer innovative and cutting edge technologies, our primary objective is to improve patient outcomes.
NANOTOMER
Industry:
Biotechnology
Founded:
2015-01-01
Address:
Boston, Massachusetts, United States
Country:
United States
Website Url:
http://www.nanotomer.com
Status:
Active
Current Employees Featured
Official Site Inspections
http://www.nanotomer.com
- Host name: unalocated.63.wixsite.com
- IP address: 185.230.63.107
- Location: Ashburn United States
- Latitude: 39.018
- Longitude: -77.539
- Metro Code: 511
- Timezone: America/New_York
- Postal: 20147
More informations about "NanoTomer"
Targeted Cancer Therapy | NanoTomer, Inc. | United States
MHA112 is our proprietary antibody developed to seek out cancer in the body. By linking MHA112 to powerful drug conjugates, we will enable the targeted delivery of highly potent active …See details»
NanoTomer - Crunchbase Company Profile & Funding
Where is NanoTomer 's headquarters? NanoTomer is located in Boston, Massachusetts, United States. Who are NanoTomer 's competitors? Alternatives and possible competitors to …See details»
NanoTomer Company Profile 2024: Valuation, Funding …
Information on valuation, funding, cap tables, investors, and executives for NanoTomer. Use the PitchBook Platform to explore the full profile.See details»
MHA112 | NanoTomer, Inc.
MHA112 is an antibody that has the ability to target primary solid tumors while simultaneously targeting any metastases in the draining lymph node and secondary tumors. MHA112 targets …See details»
Protin101 - NanoTomer, Inc.
Protin101 is a fragment of a naturally occurring protein that has targeting characteristics that have shown in pre-clinical cancer models to be effective at targeting solid tumors.See details»
NanoTomer's New Cancer Report: Early Cancer Diagnosis and …
Oct 21, 2022 · NANOTOMER is an advanced clinical-stage biopharmaceutical company developing novel therapies. It strives to change disease progression fundamentally, extending …See details»
Nanotomer, Inc Company Profile | Sudbury, MA - Dun & Bradstreet
With a Hoovers subscription you can get a comprehensive view of Nanotomer, Inc. Reach the right people with access to detailed contact information. See similar companies for insight and …See details»
NanoTomer, Inc. - VentureRadar
Website: http://www.nanotomer.com Develops targeted oncology solutions using proprietary antibody MHA112 and peptide Protin101 for drug conjugate delivery and T-cell activation in …See details»
NanoTomer - Products, Competitors, Financials, Employees, …
NanoTomer focuses on targeted oncology in the biotechnology sector. The company develops antibody and peptide drug conjugates for the targeted delivery of pharmaceuticals to treat …See details»
NanoTomer - Crunchbase
NanoTomer innovative and cutting edge technologies, our primary objective is to improve patient outcomes.See details»
NanoTomer - Overview, News & Similar companies | ZoomInfo.com
Oct 21, 2022 · View NanoTomer (www.nanotomer.com) location in Massachusetts, United States , revenue, industry and description. Find related and similar companies as well as employees …See details»
NanoTomer's New Cancer Report: Early Cancer Diagnosis and …
Oct 21, 2022 · Boston, Massachusetts--(Newsfile Corp. - October 21, 2022) - NANOTOMER brings a new targeting approach to fighting cancer treatment. ItSee details»
NanoTomer, Inc. - Drug pipelines, Patents, Clinical trials - Synapse
Explore NanoTomer, Inc. with its drug pipeline, therapeutic area, technology platform, , Disease Domain:Neoplasms, Technology Platform:Antibody drug conjugate (ADC), Peptide drug …See details»
NanoTomer - Contacts, Employees, Board Members, Advisors
NanoTomer innovative and cutting edge technologies, our primary objective is to improve patient outcomes.See details»
Joseph Kelley - Consultant/Advisor - LinkedIn
As former Vice President of Eli Lilly and Company’s Global Government and International Corporate Affairs, he has 25+ years of experience influencing public policy, and making sound …See details»
Simultaneous targeting of primary tumor, draining lymph node, …
Feb 1, 2021 · Here, we generated a novel monoclonal antibody (MHA112) against peripheral node addressin (PNAd), a family of glycoproteins expressed on high endothelial venules …See details»
NanoTomer - Tech Stack, Apps, Patents & Trademarks - Crunchbase
NanoTomer has 1 registered patent in the ' Medical Or Veterinary Science; Hygiene ' category, according to IPqwery. NanoTomer innovative and cutting edge technologies, our primary …See details»
Nanotomer, Inc - Official MapQuest
NanoTomer, Inc. is a leading targeted oncology company based in Boston, MA. Founded in 2015, their team of dedicated scientists has been at the forefront of developing innovative and …See details»
MHA-112 - Drug Targets, Indications, Patents - Synapse - Patsnap
MHA-112, Initially developed by NanoTomer, Inc., Now, its global highest R&D status is Preclinical, Therapeutic Areas: Neoplasms, Active Indication: Neoplasms, Active Org.: …See details»
NanoTemper Technologies - Crunchbase Company Profile
Mar 7, 2017 · Our mission at NanoTemper Technologies is to enable everyone to do science that matters by always pushing the limits. We’re focused on making tools that address challenging …See details»